Kristian Reich
Universität Hamburg(DE)University Medical Center Hamburg-Eppendorf(DE)Heinrich Heine University Düsseldorf(DE)
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Autoimmune Bullous Skin Diseases, Asthma and respiratory diseases, Pharmaceutical studies and practices
Most-Cited Works
- → Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials(2014)1,933 cited
- → Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)(2008)1,344 cited
- → Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial(2005)1,039 cited
- → Definition of treatment goals for moderate to severe psoriasis: a European consensus(2010)871 cited
- → Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis(2016)822 cited
- → Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials(2015)818 cited